Gilead Sciences - Getting Crushed On Mixed Results

Gilead Sciences

shares are trading lower by $10.00 at $97.18 in Wednesday's session. Mixed news for the company has investors cautious on the company moving forward. The good news for shareholders was that the company beat Q4 views ($$2.43 vs $2.19) on better than expected revenue ($7.31B vs. $6.68B). But the bad news, which the Street seems to be focusing on is the disappointing outlook issued by company. In volatile after-hours trading, the issue spiked to $109.90 before ending the session at $102.35. Investors should be aware that stocks can trade after the 4:00 PM close until 8:00 PM EST off exchange. They resume trading off-exchange trading at 4:00 AM EST. So far in today's session it has found intraday support at $95.81 and has rebounded to the $99.00 level. That level coincides with its two lows from January 13 ($95.25) and January 14 ($95.71).